159 related articles for article (PubMed ID: 20864906)
1. Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy.
Zabczyk M; Butenas S; Palka I; Nessler J; Undas A
Pol Arch Med Wewn; 2010 Sep; 120(9):334-40. PubMed ID: 20864906
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients.
Ząbczyk M; Butenas S; Plicner D; Fijorek K; Sadowski J; Undas A
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):189-94. PubMed ID: 22343680
[TBL] [Abstract][Full Text] [Related]
3. Activated factor XI and tissue factor in chronic obstructive pulmonary disease: links with inflammation and thrombin generation.
Jankowski M; Undas A; Kaczmarek P; Butenas S
Thromb Res; 2011 Mar; 127(3):242-6. PubMed ID: 21236471
[TBL] [Abstract][Full Text] [Related]
4. Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events.
Undas A; Slowik A; Gissel M; Mann KG; Butenas S
Eur J Clin Invest; 2012 Feb; 42(2):123-9. PubMed ID: 21707613
[TBL] [Abstract][Full Text] [Related]
5. Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
Paszek E; Pociask E; Ząbczyk M; Piórkowski A; Butenas S; Legutko J; Undas A
Atherosclerosis; 2022 Apr; 346():124-132. PubMed ID: 35246318
[TBL] [Abstract][Full Text] [Related]
6. Factor XIa and tissue factor activity in patients with coronary artery disease.
Butenas S; Undas A; Gissel MT; Szuldrzynski K; Zmudka K; Mann KG
Thromb Haemost; 2008 Jan; 99(1):142-9. PubMed ID: 18217146
[TBL] [Abstract][Full Text] [Related]
7. Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events.
Undas A; Slowik A; Gissel M; Mann KG; Butenas S
Thromb Res; 2011 Nov; 128(5):e62-6. PubMed ID: 21820158
[TBL] [Abstract][Full Text] [Related]
8. Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.
Luszczak J; Undas A; Gissel M; Olszowska M; Butenas S
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):473-9. PubMed ID: 21519234
[TBL] [Abstract][Full Text] [Related]
9. Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes.
Paszek E; Pociask E; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2022 Dec; 52(12):e13857. PubMed ID: 35996895
[TBL] [Abstract][Full Text] [Related]
10. Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke.
Kusak P; Czarnecka D; Gissel M; Plens K; Butenas S; Undas A
Arch Med Sci; 2016 Oct; 12(5):1000-1007. PubMed ID: 27695490
[TBL] [Abstract][Full Text] [Related]
11. Activation of the contact system in patients with a first acute myocardial infarction.
Konings J; Govers-Riemslag JW; Spronk HM; Waltenberger JL; ten Cate H
Thromb Res; 2013 Jul; 132(1):138-42. PubMed ID: 23746628
[TBL] [Abstract][Full Text] [Related]
12. Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.
Leiderman K; Chang WC; Ovanesov M; Fogelson AL
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2334-2345. PubMed ID: 27789475
[TBL] [Abstract][Full Text] [Related]
13. Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.
Puy C; Tucker EI; Matafonov A; Cheng Q; Zientek KD; Gailani D; Gruber A; McCarty OJ
Blood; 2015 Feb; 125(9):1488-96. PubMed ID: 25587039
[TBL] [Abstract][Full Text] [Related]
14. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
[TBL] [Abstract][Full Text] [Related]
15. Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.
Shupp JW; Prior SM; Jo DY; Moffatt LT; Mann KG; Butenas S
Burns; 2018 Mar; 44(2):436-444. PubMed ID: 29032977
[TBL] [Abstract][Full Text] [Related]
16. Effect of factor XI inhibition on tumor cell-induced coagulation activation.
Mäder J; Rolling CC; Voigtländer M; Schulenkorf A; Lehr C; Regenhardt J; Bokemeyer C; Beckmann L; Langer F
J Thromb Haemost; 2024 Jan; 22(1):199-212. PubMed ID: 37751848
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of factor XIa-alpha 1-antitrypsin in plasma, a contact phase-activated coagulation factor-inhibitor complex, in patients with coronary artery disease.
Murakami T; Komiyama Y; Masuda M; Karakawa M; Iwasaka T; Takahashi H
Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1107-13. PubMed ID: 7627703
[TBL] [Abstract][Full Text] [Related]
18. Increased factor XIa levels in patients with a first acute myocardial infarction: the introduction of a new thrombin generation based factor XIa assay.
Loeffen R; van Oerle R; de Groot PG; Waltenberger J; Crijns HJ; Spronk HM; ten Cate H
Thromb Res; 2014 Dec; 134(6):1328-34. PubMed ID: 25288467
[TBL] [Abstract][Full Text] [Related]
19. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood.
Hansson KM; Nielsen S; Elg M; Deinum J
J Thromb Haemost; 2014 Oct; 12(10):1678-86. PubMed ID: 25142753
[TBL] [Abstract][Full Text] [Related]
20. FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow.
Zhu S; Travers RJ; Morrissey JH; Diamond SL
Blood; 2015 Sep; 126(12):1494-502. PubMed ID: 26136249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
